Skip to content

Hematologie

02/10/2022
Hematologie

Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma.

Eur Respir J. 2022 Feb 10;59(2):2101724. doi: 10.1183/13993003.01724-2021. Print 2022 Feb.PMID: 34446469 Free PMC article. Clinical Trial. Schauwvlieghe Alexander
03/11/2021
Hematologie

Life-threatening autoimmune hemolytic anemia following mRNA COVID-19 vaccination: don’t be too prudent with the red gold.

Clin Chem Lab Med. 2022 Mar 11;60(6):e125-e128. doi: 10.1515/cclm-2022-0118. Print 2022 May 25.PMID: 35278047 Free article. No abstract available. Schauwvlieghe Alexander
06/12/2023
Hematologie

A unique phenotype of longitudinal extensive transverse myelitis in autoimmune lymphoproliferative syndrome.

J Neuroimmunol. 2022 Jun 15;367:577866. doi: 10.1016/j.jneuroim.2022.577866. Epub 2022 Apr 12.PMID: 35453041 Schauwvlieghe Alexander
10/10/2022
Hematologie

Performance of the JF5-Based Galactomannoprotein EIA Compared to the Lateral Flow Device and the Galactomannan EIA in Serum and Bronchoalveolar Lavage Fluid.

J Clin Microbiol. 2022 Oct 10:e0094822. doi: 10.1128/jcm.00948-22. Online ahead of print.PMID: 36214562 Schauwvlieghe Alexander
01/01/2022
Hematologie

Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective study from the Belgian Hematology Society (BHS).

Bone Marrow Transplant. 2022 Jan;57(1):116-118. doi: 10.1038/s41409-021-01464-x.dr. Selleslag Dominik
12/01/2021
Hematologie

Correction to: Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML.

Leukemia. 2021 Dec;35(12):3637. doi: 10.1038/s41375-021-01473-1.dr. Selleslag Dominik
06/12/2023
Hematologie

Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial.

Blood Adv. 2022 Feb 22;6(4):1115-1125. doi: 10.1182/bloodadvances.2021005624.dr. Selleslag Dominik
12/01/2022
Hematologie

Updated recommendations on the use of ruxolitinib for the treatment of myelofibrosis.

Hematology. 2022 Dec;27(1):23-31. doi: 10.1080/16078454.2021.2009645.dr. Selleslag Dominik
07/01/2022
Hematologie

Parvovirus B19-triggered hemophagocytic lymphohistiocytosis in a patient with Crohn’s disease.

Acta Gastroenterol Belg. 2022 Jul-Sep;85(3):522-524. doi: 10.51821/85.3.9108.dr. Willandt Barbaradr. Snauwaert Christophedr. Selleslag Dominikdr. Reynders Marijke
06/12/2023
Hematologie

Empiric versus pre-emptive antifungal strategy in high-risk neutropenic patients on fluconazole prophylaxis: a randomized trial of the European organization for Research and Treatment of cancer (EORTC 65091).

Clin Infect Dis. 2022 Jul 30:ciac623. doi: 10.1093/cid/ciac623.dr. Selleslag Dominik
11/01/2022
Hematologie

Postremission cytopenia management in patients with acute myeloid leukemia treated with venetoclax and azacitidine in VIALE-A.

Am J Hematol. 2022 Nov;97(11):E416-E419. doi: 10.1002/ajh.26692.dr. Selleslag Dominik
09/05/2022
Hematologie

Heterogeneity and viral replication fitness of HSV-1 clinical isolates with mutations in the thymidine kinase and DNA polymerase.

J Antimicrob Chemother. 2022 Sep 5:dkac297. doi: 10.1093/jac/dkac297.dr. Selleslag Dominikdr. Reynders Marijke
06/12/2023
Hematologie

Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study.

Blood 2022 Apr 14;139(15):2338-2346. doi: 10.1182/blood.2021013526. -PMID: 34936697 DOI: 10.1182/blood.2021013526dr. Snauwaert Sylvia
07/01/2021
Hematologie

Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML.

Leukemia. 2021 Jul;35(7):2119-2124. doi: 10.1038/s41375-021-01125-4. Epub 2021 Jan 22. PMID: 33483617 Free PMC article. Clinical Trial. No abstract available.dr. Selleslag Dominik
02/01/2021
Hematologie

Efficacy of ruxolitinib in B-lymphoblastic leukaemia with the PCM1-JAK2 fusion gene.

Br J Haematol. 2021 Feb;192(4):e112-e115. doi: 10.1111/bjh.17340. Epub 2021 Jan 27. PMID: 33502001 No abstract available.dr. Selleslag Dominik
06/12/2023
Hematologie

Primary immune thrombocytopenia in adults: Belgian recommendations for diagnosis and treatment anno 2021 made by the Belgian Hematology Society.

Acta Clin Belg. 2021 Feb 26:1-14. doi: 10.1080/17843286.2021.1876310. Online ahead of print. PMID: 33635747dr. Selleslag Dominik
06/12/2023
Hematologie

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.

N Engl J Med. 2020 Dec 24;383(26):2526-2537. doi: 10.1056/NEJMoa2004444. PMID: 33369355 Clinical Trial.dr. Selleslag Dominik
05/01/2021
Hematologie

Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice.

Adv Ther. 2021 May;38(5):2673-2688. doi: 10.1007/s12325-021-01727-5. Epub 2021 Apr 18. PMID: 33866516 Free PMC article.dr. Selleslag Dominik
07/01/2021
Hematologie

Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice-data from a Belgian registry.

Ann Hematol. 2021 Jul;100(7):1723-1732. doi: 10.1007/s00277-021-04507-x. Epub 2021 May 4. PMID: 33942128 Free PMC article.dr. Selleslag Dominik
10/01/2021
Hematologie

A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease.

Bone Marrow Transplant. 2021 Oct;56(10):2477-2488. doi: 10.1038/s41409-021-01356-0. Epub 2021 Jun 9. PMID: 34108672 Free PMC article. Clinical Trial.dr. Selleslag Dominik
06/12/2023
Hematologie

Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial.

J Hematol Oncol. 2021 Aug 28;14(1):133. doi: 10.1186/s13045-021-01142-x. PMID: 34454540 Free PMC article. Clinical Trial.dr. Selleslag Dominik
06/12/2023
Hematologie

Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase 3, placebo-controlled QUAZAR AML-001 trial.

Haematologica. 2021 Sep 23. doi: 10.3324/haematol.2021.279174. Online ahead of print. PMID: 34551506 Free article.dr. Selleslag Dominik
10/05/2021
Hematologie

Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective study from the Belgian Hematology Society (BHS).

Bone Marrow Transplant. 2021 Oct 5. doi: 10.1038/s41409-021-01464-x. Online ahead of print. PMID: 34611291 No abstract available.dr. Selleslag Dominik
06/12/2023
Hematologie

High total metabolic tumor volume at baseline predicts survival independent of response to therapy.

Blood. 2020 Apr 16;135(16):1396-1405. doi: 10.1182/blood.2019003526.PMID: 31978225 Free PMC article. Clinical Trial.dr. Snauwaert Sylvia
04/01/2020
Hematologie

Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study.

Br J Haematol. 2020 Apr;189(1):84-96. doi: 10.1111/bjh.16300. Epub 2019 Nov 8.PMID: 31702836 Free PMC article.dr. Snauwaert Sylvia
05/01/2020
Hematologie

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment.

Haematologica. 2020 May;105(5):1306-1316. doi: 10.3324/haematol.2019.222612. Epub 2019 Aug 1.PMID: 31371409 Free PMC articledr. Snauwaert Sylvia
03/01/2019
Hematologie

Guidelines of the Belgian Hematology Society on the use of stem cell transplantation in lymphoproliferative diseases.

Belgian journal of hematology volume 10 issue 2 march 2019 p 69-79.dr. Snauwaert Sylvia
11/08/2019
Hematologie

Lenalidomide maintenance for diffuse large B-cell lymphoma patients responding to R-CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study.

Br J Haematol. 2019 Nov 8. doi: 10.1111/bjh.16300. PMID: 31702836dr. Snauwaert Sylvia
08/01/2019
Hematologie

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment.

Haematologica. 2019 Aug 1. pii: haematol.2019.222612. doi: 10.3324/haematol.2019.222612. PMID: 31371409dr. Snauwaert Sylvia
08/01/2019
Hematologie

Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study.

Lancet Haematol. 2019 Aug;6(8):e429-e437. doi: 10.1016/S2352-3026(19)30089-4. Epub 2019 Jul 8. PMID: 31296423dr. Snauwaert Sylvia
01/01/2015
Hematologie

Bing-Neel Syndrome: two unexpected cases and review of the literature.

Journal of the Neurological Sciences 2015;356(1-2):19-26.dr. Emmerechts Jandr. Vanopdenbosch Ludo
01/01/2011
Hematologie

Evaluation of the profibrinolytic properties of an anti-TAFI monoclonal antibody in a mouse thromboembolism model.

Blood 2011; 117: 4615-22dr. Emmerechts Jan
01/01/2014
Hematologie

Acquired thrombin and FV inhibitors upon aortic bioprosthetic valve replacement.

Haemophilia. 2014;20(4):e354-6. doi: 10.1111/hae.12469.dr. Bourgeois Marcdr. Emmerechts Jandr. Schepens Marc
01/01/2012
Hematologie

Circulating apoptotic endothelial cells and apoptotic endothelial microparticles independently predict the presence of cardiac allograft vasculopathy.

J Am Coll Cardiol 2012; 60(4): 324-31dr. Emmerechts Jan
01/01/2012
Hematologie

Hemostatic changes in young and old mice upon subchronic exposure to air pollution in an urban roadside tunnel.

Thromb Haemost 2012; 108(4): 756-68.dr. Emmerechts Jan
01/01/2012
Hematologie

Changed gene expression in brains of mice exposed to traffic in a highway tunnel.

Inhalation Toxicology 2012; 24(10): 676-686.dr. Emmerechts Jan
01/01/2012
Hematologie

Antidote strategies to reverse anticoagulation with TB-402, a long-acting partial inhibitor of FVIII.

J Thromb Haemost 2012; 10(7): 1371-8.dr. Emmerechts Jan
01/01/2012
Hematologie

Effect of ageing on the murine venous circulation.

Histochem Cell Biol 2012; 137(4): 537-46dr. Emmerechts Jan
01/01/2012
Hematologie

Air pollution-associated procoagulant changes: role of circulating microvesicles.

J Thromb Haemost 2012;1 0(1): 96-106dr. Emmerechts Jan
01/01/2012
Hematologie

The effect of air pollution on hemostasis.

Hamostaseologie 2012; 32(1): 5-13dr. Emmerechts Jan
01/01/2012
Hematologie

Microparticle number or procoagulant activity are not upregulated in healthy elderly persons.

Thromb Res. 2012;129(1): 98-100dr. Emmerechts Jan
01/01/2012
Hematologie

Circulating apoptotic endothelial cells and apoptotic endothelial microparticles independently predict the presence of cardiac allograft vasculopathy.

J Am Coll Cardiol 2012; 60(4): 324-31dr. Emmerechts Jan
01/01/2012
Hematologie

Hemostatic changes in young and old mice upon subchronic exposure to air pollution in an urban roadside tunnel.

Thromb Haemost 2012; 108(4): 756-68.dr. Emmerechts Jan
01/01/2012
Hematologie

Changed gene expression in brains of mice exposed to traffic in a highway tunnel.

Inhalation Toxicology 2012; 24(10): 676-686.dr. Emmerechts Jan
01/01/2012
Hematologie

Antidote strategies to reverse anticoagulation with TB-402, a long-acting partial inhibitor of FVIII.

J Thromb Haemost 2012; 10(7): 1371-8.dr. Emmerechts Jan
01/01/2012
Hematologie

Effect of ageing on the murine venous circulation.

Histochem Cell Biol 2012; 137(4): 537-46dr. Emmerechts Jan
01/01/2012
Hematologie

Air pollution-associated procoagulant changes: role of circulating microvesicles.

Thromb Haemost 2012;1 0(1): 96-106dr. Emmerechts Jan
01/01/2012
Hematologie

Partial versus complete factor VIII inhibition in a mouse model of venous thrombosis.

Thromb Res. 2012; 129(4): 514-9dr. Emmerechts Jan
01/01/2012
Hematologie

The effect of air pollution on hemostasis.

Hamostaseologie 2012; 32(1): 5-13dr. Emmerechts Jan
01/01/2011
Hematologie

The influence of air pollution on health: mechanistic implications.

Verh K Acad Geneeskd Belg 2011; 73(5-6): 339-51dr. Emmerechts Jan
01/01/2011
Hematologie

Effecten van fijn stof op bloedplaatjesactivatie en atherosclerose in een populatie van diabetespatiënten.

Vlaams Tijdschrift voor Diabetologie 2011, 2: 19-21dr. Emmerechts Jan
01/01/2011
Hematologie

The impact of air pollution on health, economy, environment and agricultural sources.

Rijeka: Croatia InTech 2011; 69-92.dr. Emmerechts Jan
01/01/2011
Hematologie

Progression of the pro-thrombotic state in ageing BMAL1 deficient mice.

Arterioscler Thromb Vasc Biol 2011; 31: 2552-9dr. Emmerechts Jan
01/01/2011
Hematologie

Correction of endothelial dysfunction after selective homocysteine lowering gene therapy reduces arterial thrombosis but has no effect on atherogenesis.

J Mol Med 2011; 89: 1051-8dr. Emmerechts Jan
01/01/2011
Hematologie

Evaluation of the profibrinolytic properties of an anti-TAFI monoclonal antibody in a mouse thromboembolism model.

Blood 2011; 117: 4615-22dr. Emmerechts Jan
01/01/2011
Hematologie

Traffic Air Pollution and Oxidized LDL.

PLoS One 2011; 6: e16200dr. Emmerechts Jan
01/01/2011
Hematologie

Air pollution and cardiovascular disease.The impact of air pollution on health, economy, environment and agricultural sources.

Khallaf (ed). Rijeka: Croatia, InTech 2011; 69-92.dr. Emmerechts Jan
01/01/2011
Hematologie

The influence of air pollution on health: mechanistic implications.

Verh K Acad Geneeskd Belg 2011; 73(5-6): 339-51dr. Emmerechts Jan
01/01/2011
Hematologie

Effecten van fijn stof op bloedplaatjesactivatie en atherosclerose in een populatie van diabetespatiënten.

Vlaams Tijdschrift voor Diabetologie 2011, 2: 19-21dr. Emmerechts Jan
01/01/2011
Hematologie

Progression of the pro-thrombotic state in ageing BMAL1 deficient mice.

Arterioscler Thromb Vasc Biol 2011; 31: 2552-9dr. Emmerechts Jan
01/01/2011
Hematologie

Correction of endothelial dysfunction after selective homocysteine lowering gene therapy reduces arterial thrombosis but has no effect on atherogenesis.

J Mol Med 2011; 89: 1051-8dr. Emmerechts Jan
01/01/2011
Hematologie

Traffic Air Pollution and Oxidized LDL.

PLoS One 2011; 6: e16200dr. Emmerechts Jan
01/01/2010
Hematologie

Short-term exposure to particulate matter induces arterial but not venous thrombosis in healthy mice.

J Thromb Haemost 2010; 8: 2651-2661dr. Emmerechts Jan
01/01/2010
Hematologie

Air pollution related prothrombotic changes in persons with diabetes.

Environ Health Perspect 2010; 118: 191-196dr. Emmerechts Jan
01/01/2010
Hematologie

Short-term exposure to particulate matter induces arterial but not venous thrombosis in healthy mice.

J Thromb Haemost 2010; 8: 2651-2661dr. Emmerechts Jan
01/01/2010
Hematologie

Air pollution related prothrombotic changes in persons with diabetes.

Environ Health Perspect 2010; 118: 191-196dr. Emmerechts Jan
01/01/1970
Hematologie

Het endotheel: tussen hemostase en inflammatie.

De Agenda Cardiologie 2008; 22: 4-6dr. Emmerechts Jan
01/01/2008
Hematologie

Het endotheel: tussen hemostase en inflammatie.

De Agenda Cardiologie 2008; 22: 4-6dr. Emmerechts Jan
Geen podcAZts gevonden...
Geen media gevonden...
Geen evenement gevonden...